Introduction
Knowing who manufactures a medicine is an important part of making an informed healthcare decision. Manufacturer information helps patients, pharmacists and healthcare professionals identify the product, check its origin and consult the correct prescribing documentation.
Resiliva is identified on this website as a product containing resmetirom in stated 80 mg and 100 mg strengths. However, the specific legal manufacturer, marketing authorization holder and manufacturing location of Resiliva have not been independently established from the documentation currently available for this website.
For that reason, this page does not attribute Resiliva to a company without reliable evidence. The absence of a verified manufacturer name should be resolved before publishing any claim that identifies a particular company as the manufacturer or authorization holder.
The Developer of Resmetirom
Resmetirom is the active ingredient in the established reference product REZDIFFRA. Madrigal Pharmaceuticals developed the medicine and commercializes the reference product in the United States.
The U.S. Food and Drug Administration approved REZDIFFRA in March 2024 for a defined group of adults with noncirrhotic NASH and moderate to advanced liver fibrosis, in conjunction with diet and exercise.
This information concerns the development and authorization of the reference product. It does not establish that Madrigal Pharmaceuticals manufactures, distributes or authorizes Resiliva.
Different products containing the same active ingredient may have different manufacturers, packaging, excipients, regulatory status and distribution arrangements. Each product must be assessed using its own documentation.
Why Manufacturer Verification Matters
Pharmaceutical manufacturing involves controls intended to support medicine identity, strength, purity and consistent quality. Manufacturer verification helps establish where a medicine was produced and which organization is responsible for the relevant manufacturing activities.
The manufacturer named on a package may not always be the same as the marketing authorization holder, importer or distributor. These roles should be distinguished when interpreting product information.
A product’s legal manufacturer is also not necessarily the original developer of its active ingredient. This distinction is particularly important when comparing a branded product with an established reference medicine.
What Information Should Be Checked?
Before relying on the manufacturer information for Resiliva, review the following details.
Legal manufacturer
Look for the full legal company name and manufacturing address on the packaging or official product documentation. If multiple facilities are listed, confirm the role of each facility.
Marketing authorization holder
Where applicable, identify the organization responsible for the product’s marketing authorization. This company may differ from the physical manufacturer.
Product registration
Check whether the exact product name, strength and dosage form appear in the relevant national medicines registration database. Confirm that the registration is current and applies to the country in which the medicine is being supplied.
Batch and expiry information
The package should contain appropriate batch or lot identification and an expiry date. These details should be legible and consistent with the accompanying documentation.
Package insert
Review the product-specific insert for the active ingredient, strength, approved uses, dosage instructions, contraindications, warnings, storage conditions and company details.
How to Verify a Pharmaceutical Product
Patients and healthcare professionals can take several practical steps when assessing product identity.
First, inspect the complete package and check whether the medicine’s name, strength and dosage form are clearly stated. Compare this information with the accompanying package insert.
Second, ask a licensed pharmacist to review the product and its source. A pharmacist may be able to identify inconsistencies or determine whether additional documentation is required.
Third, consult the medicines regulatory authority responsible for the country where the medicine is being supplied. A registration entry should match the exact product and relevant authorization details.
Finally, contact the named manufacturer or authorization holder through independently verified contact information if questions remain. Avoid relying exclusively on telephone numbers, websites or contact details printed on an unverified package.
Manufacturer Claims and Product Authenticity
A company’s name appearing on a website is not, by itself, proof that the company manufactured or authorized a medicine. Likewise, a professional-looking package, a barcode or a QR code does not independently establish authenticity.
Product authenticity should be assessed using reliable records and the appropriate supply chain. Where doubts persist, a patient should ask a healthcare professional or regulator how to proceed before using the medicine.
Do not publish claims that Resiliva is manufactured by Madrigal Pharmaceuticals or another specific company unless supporting documentation confirms the relationship.
Quality, Storage and Handling
Storage conditions depend on the exact formulation and the manufacturer’s approved instructions. Users should follow the conditions specified in the product’s official package insert rather than assuming that Resiliva has the same requirements as REZDIFFRA.
Medicines should be kept in their original packaging when appropriate, protected according to the stated storage instructions and kept out of reach of children. Do not use a product that has expired or whose packaging appears compromised without obtaining professional advice.
Information for Healthcare Professionals
Healthcare professionals reviewing Resiliva may wish to obtain the product’s full prescribing information, registration documentation, manufacturer details and relevant quality documentation before making product-specific decisions.
If the product is supplied across borders, additional verification may be necessary to establish the legality of importation and the applicable regulatory requirements.
The active ingredient alone is not sufficient to establish pharmaceutical equivalence or interchangeability. Decisions should be based on reliable product-specific evidence and applicable local regulations.
Medical Disclaimer
This page provides general information about manufacturer verification. It does not certify Resiliva as authentic, approved, safe for an individual patient or equivalent to REZDIFFRA.
The manufacturer and regulatory status of Resiliva must be established using official product documentation and reliable regulatory records.
References
- U.S. Food and Drug Administration: REZDIFFRA approval information and prescribing information.
- European Medicines Agency: REZDIFFRA product information.
- Relevant national medicines regulatory authority: Product registration and manufacturer records.